Blog: Patient Insights & Thought Leadership

Healthcare Industry Thought Leadership

Health Union’s data-driven industry conversations help pharma make smarter, more effective decisions.
Check out our latest thought leadership pieces below.

Healthcare Geofencing: The What & Why

November 20, 2023

Healthcare geofencing campaigns use programmatic technology that leverages GPS signals from HCPs’ devices and delivers ads based on this data.

Photos of Sharron Rouse and Shoshana Lipson two of Health Union’s 2023 Social Health Award winners, at Digital Pharma East 2023

Patient Leader Perspectives: Co-Design with ‘Patients from the Start’

November 1, 2023

These two accomplished patient leaders combined their experiences and perspectives to explain how industry can integrate “patients from the start.”

A pair of hands hold up a photo of a couple ripped in half around them are rain drops with question marks in them and waves below

Understanding Rare Conditions: The Impact on Relationships

September 26, 2023

Findings from Health Union’s surveys of its rare condition communities show one’s relationships and social life can take significant hits.

NPI Targeting: 3 Reasons It’s a Healthcare Advertiser’s Best Friend

August 14, 2023

A 1:1 relationship with HCPs isn't a guarantee. NPI targeting significantly increases the likelihood that happens.

HIV Patient-Reported Survey Data

December 7, 2020

New survey data shows 90% of people living with HIV feel controlled on their current treatment plan, but continue to struggle with great challenges.

Cystic Fibrosis Patient-Reported Survey Data

November 24, 2020

Cystic fibrosis survey data reveals that many people living with CF are hopeful and optimistic, yet the future is unknown.

Parkinson’s Disease Patient-Reported Survey Data

November 23, 2020

New Health Union survey data reveals interesting differences in the patient journeys of men and women living with Parkinson’s disease.

Spondyloarthritis Patient-Reported Survey Data

November 18, 2020

Survey data uncovers the often difficult spondyloarthritis diagnosis journey, showing that 83% of respondents with nr-AxSpA were initially misdiagnosed.

Healthcare Industry Thought Leadership

Contact